Ticker Details
Viatris Inc.
IPO Date:	November 13, 2020
Sector:	Healthcare
Industry:	Pharma
Market Cap:	$15.85B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.15 | 1.31%
Avg Daily Range (30 D):	$0.20 | 1.44%
Avg Daily Range (90 D):	$0.18 | 1.30%

Institutional Daily Volume
Avg Daily Volume:	8.15M
Avg Daily Volume (30 D):	7.49M
Avg Daily Volume (90 D):	6.91M

Trade Size
Avg Trade Size (Sh.):	188
Avg Trade Size (Sh.) (30 D):	143
Avg Trade Size (Sh.) (90 D):	143

Institutional Trades
Total Institutional Trades:	9,286
Avg Institutional Trade:	$4.63M
Avg Institutional Trade (30 D):	$6.82M
Avg Institutional Trade (90 D):	$5.5M
Avg Institutional Trade Volume:	.4M
Avg Institutional Trades (Per Day):	6

Market Closing Trades
Avg Closing Trade:	$17.73M
Avg Closing Trade (30 D):	$32.75M
Avg Closing Trade (90 D):	$26.98M
Avg Closing Volume:	1.55M

News

Apr 10, 2026 @ 10:59 AM Opus Genetics Announces Data Presentations at the ... Source: Na

Apr 2, 2026 @ 7:04 AM Viatris at $14: A Double-Digit FCF Yield Hiding in... Source: Gurufocus

Apr 1, 2026 @ 5:00 PM Systemic Lupus Erythematosus Clinical Trial Pipeli... Source: Delveinsight

Feb 26, 2026 @ 11:55 AM Viatris Maintains Dividend Policy for 2026 and Ann... Source: Prnewswire

Jan 28, 2026 @ 6:00 PM Chronic and Acute Pain Clinical Trial Pipeline Ana... Source: Delveinsight

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-3	$-.3	$-3
Diluted EPS	$-3	$-.3	$-3
Revenue	$14.3B	$3.7B	$14.3B
Gross Profit	$5.01B	$1.15B	$5.01B
Net Income / Loss	$-3514.9M	$-340.1M	$-3514.9M
Operating Income / Loss	$-2663.1M	$-192.7M	$-2663.1M
Cost of Revenue	$9.29B	$2.56B	$9.29B
Net Cash Flow	$611.9M	$344.5M	$611.9M
PE Ratio

Splits
Oct 09, 2003	3:2
Jan 28, 2003	3:2